Heather L Moore1,2, Thomas Kelly3, Alexandra Bright1, Robert H Field1, Andrew M Schaefer1, Alasdair P Blain1, Robert W Taylor1, Robert McFarland1, Doug M Turnbull1, Gráinne S Gorman1. 1. Wellcome Centre for Mitochondrial Research Institute of Neuroscience Newcastle University Newcastle upon Tyne NE2 4HH United Kingdom. 2. Institute of Health & Society Newcastle University 3rd Floor, Sir James Spence Institute Royal Victoria Infirmary Queen Victoria Road Newcastle upon Tyne NE1 4LP United Kingdom. 3. Department of Neuropsychology Royal Victoria Infirmary The Newcastle upon Tyne Hospitals NHS Foundation Trust Newcastle upon Tyne NE1 4LP United Kingdom.
Abstract
OBJECTIVE: To determine the cognitive profile of adult patients with mitochondrial disease, and the effect of disease severity on cognition. METHODS: Using a prospective case-control design, we compared cognition of patients to normative data and to matched controls, assessed three times over 18 months. Forty-nine patients with m.3243A>G (N = 36) and m.8344A>G (N = 13) mtDNA mutations and 32 controls, matched by age (±5 years) and premorbid cognition (±10 WTAR FSIQ points), participated. Participants completed neuropsychological assessments of general cognition (WAIS-IV), executive function (D-KEFS), and memory (WMS-IV). Potential predictors of cognition were explored. RESULTS: Patients show mild-to-moderate premorbid cognitive impairment, but substantial impairment in current general cognition and distinct domains, including verbal comprehension, perceptual reasoning, working memory, processing speed, and memory retrieval. Executive dysfunction may be caused by slower decision-making. Patients performed worse than controls, except on memory tasks, indicating intact memory, when premorbid cognition is controlled for. Premorbid cognition and disease severity were consistent predictors of cognition in patients; however, cognitive decline appears slow and is unlikely in the short-term, when other disease-specific factors remain stable. INTERPRETATION: Patients should be monitored to facilitate early identification of a complex profile of cognitive deficits and individuals with higher disease burden should be followed up more closely. On development of cognitive difficulties, appropriate compensatory strategies should be determined through in-depth assessment. Using strategies such as slower presentation of information, multiple modes of presentation, active discussion to aid understanding and decision-making, and use of memory aids, may ameliorate difficulties.
OBJECTIVE: To determine the cognitive profile of adult patients with mitochondrial disease, and the effect of disease severity on cognition. METHODS: Using a prospective case-control design, we compared cognition of patients to normative data and to matched controls, assessed three times over 18 months. Forty-nine patients with m.3243A>G (N = 36) and m.8344A>G (N = 13) mtDNA mutations and 32 controls, matched by age (±5 years) and premorbid cognition (±10 WTAR FSIQ points), participated. Participants completed neuropsychological assessments of general cognition (WAIS-IV), executive function (D-KEFS), and memory (WMS-IV). Potential predictors of cognition were explored. RESULTS: Patients show mild-to-moderate premorbid cognitive impairment, but substantial impairment in current general cognition and distinct domains, including verbal comprehension, perceptual reasoning, working memory, processing speed, and memory retrieval. Executive dysfunction may be caused by slower decision-making. Patients performed worse than controls, except on memory tasks, indicating intact memory, when premorbid cognition is controlled for. Premorbid cognition and disease severity were consistent predictors of cognition in patients; however, cognitive decline appears slow and is unlikely in the short-term, when other disease-specific factors remain stable. INTERPRETATION: Patients should be monitored to facilitate early identification of a complex profile of cognitive deficits and individuals with higher disease burden should be followed up more closely. On development of cognitive difficulties, appropriate compensatory strategies should be determined through in-depth assessment. Using strategies such as slower presentation of information, multiple modes of presentation, active discussion to aid understanding and decision-making, and use of memory aids, may ameliorate difficulties.
Authors: Maria Pachalska; Salvatore DiMauro; Maria Formińska-Kapuścik; Henryk Kurzbauer; Jan Talar; Bruce Duncan MacQueen; Iwona Pawlicka; Irena Jeleńska-Szyguła Journal: Med Sci Monit Date: 2002-02
Authors: B McGurn; J M Starr; J A Topfer; A Pattie; M C Whiteman; H A Lemmon; L J Whalley; I J Deary Journal: Neurology Date: 2004-04-13 Impact factor: 9.910
Authors: R Montirosso; D Brambilla; G Felisari; F Sclaunich; E Filipponi; U Pozzoli; N Bresolin Journal: J Neurol Sci Date: 2002-02-15 Impact factor: 3.181
Authors: A C Turconi; R Benti; E Castelli; S Pochintesta; G Felisari; G Comi; C Gagliardi; L Del Piccolo; N Bresolin Journal: J Neurol Sci Date: 1999-11-15 Impact factor: 3.181
Authors: K A M Majamaa-Voltti; S Winqvist; A M Remes; U Tolonen; J Pyhtinen; S Uimonen; M Kärppä; M Sorri; K Peuhkurinen; K Majamaa Journal: Neurology Date: 2006-05-23 Impact factor: 9.910
Authors: P Kaufmann; D C Shungu; M C Sano; S Jhung; K Engelstad; E Mitsis; X Mao; S Shanske; M Hirano; S DiMauro; D C De Vivo Journal: Neurology Date: 2004-04-27 Impact factor: 9.910
Authors: Kim F E van de Loo; Nander T van Zeijl; Mirian C H Janssen; Christianne M Verhaak; José A E Custers Journal: Orphanet J Rare Dis Date: 2022-07-15 Impact factor: 4.303
Authors: Roy A M Haast; Irenaeus F M De Coo; Dimo Ivanov; Ali R Khan; Jacobus F A Jansen; Hubert J M Smeets; Kâmil Uludağ Journal: Brain Commun Date: 2022-02-03
Authors: Kim F E van de Loo; José A E Custers; Lonneke de Boer; Marloes van Lieshout; Maaike C de Vries; Mirian C H Janssen; Christianne M Verhaak Journal: Orphanet J Rare Dis Date: 2022-10-01 Impact factor: 4.303